Insulin glargine and Lotemax (Loteprednol Eye Drops 0.5% and 1%)
Determining the interaction of Insulin glargine and Lotemax (Loteprednol Eye Drops 0.5% and 1%) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
Generic Name: loteprednol ophthalmic
Brand name: Alrex, Inveltys, Lotemax, Lotemax SM
Synonyms: Lotemax (ophthalmic), Lotemax
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine-Lotemax (Loteprednol Eye Gel)
- Insulin glargine-Lotemax (Loteprednol Eye Ointment)
- Insulin glargine-Lotemax Eye Gel
- Insulin glargine-Lotemax Eye Ointment
- Insulin glargine-Lotemax ophthalmic
- Insulin glargine-Lotemax SM
- Lotemax (Loteprednol Eye Drops 0.5% and 1%)-Insulin Glargine (U-100) Cartridge Systems and Pens
- Lotemax (Loteprednol Eye Drops 0.5% and 1%)-Insulin Glargine (U-100) Vials
- Lotemax (Loteprednol Eye Drops 0.5% and 1%)-Insulin Glargine (U-300) Pens
- Lotemax (Loteprednol Eye Drops 0.5% and 1%)-Insulin glargine and lixisenatide
- Lotemax (Loteprednol Eye Drops 0.5% and 1%)-Insulin glargine and lixisenatide Subcutaneous
- Lotemax (Loteprednol Eye Drops 0.5% and 1%)-Insulin glargine, recombinant Subcutaneous